Marc Iskowitz, Beghou
The Space: Life Sciences Podcast
Marc Iskowitz, Beghou's editorial director, hosts behind-the-scenes conversations with biopharma executives. This series will feature leaders from across the biotech and pharma ecosystem, spanning commercial ops, field force, medical, marketing, analytics, market access, and beyond, sharing real-world lessons from the front lines of bringing therapies to patients.
Autor
Marc Iskowitz, Beghou
Kategorie
Podcast-Website
Neueste Folge
17. Jun 2026
Wo hören?
Podcasts in der App Replaio Radio Bald verfügbarPodcasts kommen bald in die App. Installiere sie jetzt und erlebe als Erster einen ganz neuen Blick auf Podcasts
Folgen
Why capital efficiency anchors biotech’s new commercial playbook 17.06.2026 25:50
As biotech navigates a mixed funding and dealmaking environment in 2026, one principle continues to guide the commercial playbook: capital efficiency. So says Jacob Lai, Vice President and Head of Commercial at Star Therapeutics, who sat down with Marc Iskowitz in the latest episode of The Space Life Sciences Podcast to discuss how that environment is shaping go-to-market strategy. Jacob explains...
Moving clinical minds: Why strong data don't always translate into clinical adoption 21.05.2026 28:07
"If the evidence is compelling, why isn't practice evolving?" That was Audrey Carnevale's “welcome to pharma” moment — the realization that strong data doesn't automatically translate into changes in clinical adoption. Now Associate Director of Medical Communications at Averitas Pharma (and an MSL before that), Audrey joins Marc Iskowitz in the second episode of The Space pod...
Fixing pre-launch commercial ops mistakes 27.04.2026 18:30
Operating model. Launch readiness. Data. Execution. Get these wrong, and even the most promising therapy can stall. Get them right, and you get product to patient — and that’s what drives Lori Nemyier every day. In this inaugural episode of the Space Life Sciences Podcast , Marc Iskowitz sits down with Lori to unpack a critical question for emerging biotechs: Why do so many companies struggle to...
Ähnliche Podcasts
Replaio ist kein Herausgeber von Podcasts; die Namen der Sendungen, Cover und Audioinhalte gehören ihren Autoren und werden über öffentliche RSS-Feeds verbreitet